MAPK3 and Cerebral ischemia: Our data suggest for the first time that the enhanced expression of iNOS, IL-1ß, IL-6 and TNF-α in cerebral ischemia is a transcription/translational event in brain vessels, and points to a way to modify their expression by MEK/ERK1/2 inhibition.